Drawing for MD1003

USPTO serial 79251656

MD1003

Reviewed by CopyMark Law Group

Reg. 5809661Status 709
Filing date
Status date
Registration date
Jul 23, 2019
Examiner
BELL, MARLENE D
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MD1003?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the treatment of disorders of the nervous system, veterinary products for the treatment of disorders of the nervous system, chemical preparations for medical or pharmaceutical use for the treatment of disorders of the nervous system, medicinal herbsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 6, 2026C71TCANCELLED SECTION 71—
May 15, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 27, 2019GPNXNOTIFICATION PROCESSED BY IB—
Sep 9, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 9, 2019FIMPFINAL DISPOSITION PROCESSED—
Aug 22, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jul 23, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2019NPUBNOTICE OF PUBLICATION—
Mar 22, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2019DOCKASSIGNED TO EXAMINER—
Mar 1, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 14, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance